Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Published Date: 13 Dec 2024

Benefit seen in all prespecified subgroups, including high-risk patients

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pollution exposure may affect lung cancer in women who have never smoked

2.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

3.

Approved BTK Inhibitor Without Covalent Bond for CLL.

4.

Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot